The traditional means of measuring quality in health care focuses on processes, rather than disease outcomes, so providers often are forced to check off boxes without really focusing on the health status of the patients they are treating. These measures aren’t based on the care patients actually received, and they don’t truly capture what every provider can do to prevent bad outcomes.
With support from RWJF's Pioneer Portfolio, the National Committee for Quality Assurance (NCQA) is evaluating a promising way of measuring quality that focuses on improving health outcomes for patients with heart disease and diabetes. Called the Global Cardiovascular Risk Score (GCVR), this new approach is being co-developed by NCQA and Archimedes, Inc., another Pioneer grantee. The GCVR score is seen as a next-generation quality improvement tool that will provide much more accurate and effective incentives to providers for preventing disease.
The GCVR score has the potential to transform how providers, patients and payers view the measurement of health care quality because it will assess how well providers engage in prevention strategies to keep high-risk patients as healthy as possible.